Literature DB >> 25757117

Using the age-adjusted Charlson comorbidity index to predict outcomes in emergency general surgery.

Etienne St-Louis1, Sameena Iqbal, Liane S Feldman, Monisha Sudarshan, Dan L Deckelbaum, Tarek S Razek, Kosar Khwaja.   

Abstract

BACKGROUND: We evaluated the role of the Charlson age-comorbidity index (CACI), a weighted comorbidity index that reflects cumulative increased likelihood of 1-year mortality, in predicting perioperative outcomes in an emergency general surgery population at a large Canadian teaching hospital.
METHODS: A retrospective chart review of emergency general surgery admissions in 2010 was conducted. Patients who had surgery were identified. Mode of surgery and CACI were recorded, as well as measures of outcome, including 30-day mortality and intensive care unit (ICU) admission. A multivariate stepwise logistic regression model was created to assess the effect of age-adjusted Charlson comorbidity index on postoperative outcomes while controlling for the effect of possible confounders. The prediction ability of CACI for mortality was assessed using receiver operating characteristic analyses considering the area under the curve and its 95% confidence intervals (CIs).
RESULTS: Of the 529 admissions to general surgery from the emergency department, 257 patients underwent a surgical intervention. The CACI scores ranged from 0 to 16. We described a total of 11 deaths (4.3%) and 30 ICU admissions (11.7%). CACI was associated with an increased risk of 30-day mortality (adjusted odds ratio,1.39; 95% CI, 1.11-1.73; p = 0.0034). Receiver operating characteristic analysis was consistent with high accuracy of CACI for mortality prediction alone, resulting in area under the curve or c statistic of 0.90 (95% CI, 0.84-0.95). CACI was similar in predicting mortality to a multivariate model. CACI was also found to be associated with ICU admission (adjusted odds ratio, 1.17; 95% CI, 1.01-1.37; p < 0.0382). CACI is not as good a predictor for ICU admission when compared with the multivariate model.
CONCLUSION: We have shown that the CACI is a valid tool for 30-day mortality prediction in the context of emergency general surgery. LEVEL OF EVIDENCE: Prognostic study, level III.

Entities:  

Mesh:

Year:  2015        PMID: 25757117     DOI: 10.1097/TA.0000000000000457

Source DB:  PubMed          Journal:  J Trauma Acute Care Surg        ISSN: 2163-0755            Impact factor:   3.313


  25 in total

1.  A different perspective for morbidity related to Fournier's gangrene: which scoring system is more reliable to predict requirement of skin graft and flaps in survivors of Fournier's gangrene?

Authors:  Ismail Selvi; Aykut Aykac; Ozer Baran; Salih Burlukkara; Ugur Ozok; Mehmet Melih Sunay
Journal:  Int Urol Nephrol       Date:  2019-06-08       Impact factor: 2.370

2. 

Authors:  Berrin Günaydın; Ömer Kurtipek
Journal:  Turk J Anaesthesiol Reanim       Date:  2018-06-01

3.  Reduced Opioid Prescription Practices and Duration of Stay after TAP Block for Laparoscopic Appendectomy.

Authors:  Matthew C Hernandez; Eric J Finnesgard; Johnathon M Aho; Martin D Zielinski; Henry J Schiller
Journal:  J Gastrointest Surg       Date:  2019-01-22       Impact factor: 3.452

4.  The outcomes of the elderly in acute care general surgery.

Authors:  E St-Louis; M Sudarshan; M Al-Habboubi; M El-Husseini Hassan; D L Deckelbaum; T S Razek; L S Feldman; K Khwaja
Journal:  Eur J Trauma Emerg Surg       Date:  2015-04-08       Impact factor: 3.693

5.  Prophylactic Ureteral Stent Placement vs No Ureteral Stent Placement During Open Colectomy.

Authors:  Jonathan Merola; Brian Arnold; Valerie Luks; Christopher Ibarra; Benjamin Resio; Kimberly A Davis; Kevin Y Pei
Journal:  JAMA Surg       Date:  2018-01-01       Impact factor: 14.766

6.  Comparable perioperative outcomes, long-term outcomes, and quality of life in a retrospective analysis of ulcerative colitis patients following 2-stage versus 3-stage proctocolectomy with ileal pouch-anal anastomosis.

Authors:  Grace C Lee; Sarah E Deery; Hiroko Kunitake; Caitlin W Hicks; Adriana G Olariu; Lieba R Savitt; Ashwin N Ananthakrishnan; Rocco Ricciardi; Richard A Hodin; Liliana G Bordeianou
Journal:  Int J Colorectal Dis       Date:  2019-01-04       Impact factor: 2.571

7.  Characterizing the Acute Phase Response in Healthy Patients Following Total Joint Arthroplasty: Predictable and Consistent.

Authors:  William K Oelsner; Stephen M Engstrom; Michael A Benvenuti; Thomas J An; Richard A Jacobson; Gregory G Polkowski; Jonathan G Schoenecker
Journal:  J Arthroplasty       Date:  2016-07-15       Impact factor: 4.757

8.  Validation of the All Patient Refined Diagnosis Related Group (APR-DRG) Risk of Mortality and Severity of Illness Modifiers as a Measure of Perioperative Risk.

Authors:  Patrick J McCormick; Hung-Mo Lin; Stacie G Deiner; Matthew A Levin
Journal:  J Med Syst       Date:  2018-03-22       Impact factor: 4.460

9.  Components of Hospital Perioperative Infrastructure Can Overcome the Weekend Effect in Urgent General Surgery Procedures.

Authors:  Anai N Kothari; Matthew A C Zapf; Robert H Blackwell; Talar Markossian; Victor Chang; Zhiyong Mi; Gopal N Gupta; Paul C Kuo
Journal:  Ann Surg       Date:  2015-10       Impact factor: 12.969

10.  Trauma and nontrauma damage-control laparotomy: The difference is delirium (data from the Eastern Association for the Surgery of Trauma SLEEP-TIME multicenter trial).

Authors:  Kaitlin McArthur; Cassandra Krause; Eugenia Kwon; Xian Luo-Owen; Meghan Cochran-Yu; Lourdes Swentek; Sigrid Burruss; David Turay; Chloe Krasnoff; Areg Grigorian; Jeffry Nahmias; Ahsan Butt; Adam Gutierrez; Aimee LaRiccia; Michelle Kincaid; Michele N Fiorentino; Nina Glass; Samantha Toscano; Eric Ley; Sarah R Lombardo; Oscar D Guillamondegui; James M Bardes; Connie DeLa'O; Salina M Wydo; Kyle Leneweaver; Nicholas T Duletzke; Jade Nunez; Simon Moradian; Joseph Posluszny; Leon Naar; Haytham Kaafarani; Heidi Kemmer; Mark J Lieser; Alexa Dorricott; Grace Chang; Zoltan Nemeth; Kaushik Mukherjee
Journal:  J Trauma Acute Care Surg       Date:  2021-07-01       Impact factor: 3.697

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.